With scores of scientists exploring dozens of ideas on how to detect or even cure ovarian cancer, the Rivkin Center is on the cutting edge of ovarian cancer research. We keep a finger on the pulse of research from the world over, and we’ll share it with you here, along with news and insights from our staff, Scientific Board, other experts in the field, and patients and family members affected by ovarian cancer.

The Rikvin Center to Host 1st NW Gynecological Cancer Symposium

Free event to foster collaboration between scientists SEATTLE – Dec 1, 2017 – The Rivkin Center for Ovarian Cancer is proud to present the 1st biennial Northwest Gynecological Cancer Symposium (NGCS) to be held on Monday, December 4th, 2017 from 8am – 7pm at Pelton Auditorium at Fred Hutch in Seattle. NGCS is designed to […]

Highlights of Ovarian Cancer Science from ASCO

Dr. Rivkin and I attended the annual meeting of the American Society of Clinical Oncology (ASCO)—a gathering of 38,000 oncology experts from all over the world—in early June in Chicago, Illinois. In addition to oncologists, the attendees included researchers, educators, advocates, research funders, survivors and representatives from genetic testing, drug and other services companies. Our […]

New study extends benefit of Rucaparib PARP inhibitor to women with BRCA defects in tumors who do not carry inherited BRCA mutations

A study published in Lancet Oncology by Dr. Iain McNeish (2016 Rivkin Pilot Award Recipient), Dr. Elizabeth Swisher (2009 Rivkin Pilot Award Recipient), and colleagues provided key data that helped fuel the FDA’s recent approval of rucaparib for ovarian cancers with defects in the BRCA1 and BRCA2 genes in women previously treated with two or more chemotherapies.

Shop Makers Mercantile During Ovarian Cancer Awareness Month

Long-term Rivkin Center partner, Skacel Collection, Inc. is launching a special promotion this September through their Makers Mercantile site! In honor of Ovarian Cancer Awareness Month and inspired by the Skacel family’s commitment to supporting ovarian cancer research, the company is offering a 10% discount off your ENTIRE purchase, which results in a 10% donation […]

X